Last reviewed · How we verify
Soluvit
At a glance
| Generic name | Soluvit |
|---|---|
| Sponsor | Radboud University Medical Center |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Shorter Weaning From Invasive Ventilation With Levosimendan (PHASE4)
- Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock (PHASE3)
- Intracoronary Administration of Levosimendan in Cardiac Surgery Patients (PHASE4)
- Effect of Levosimendan or Placebo on Exercise in Advanced Chronic Heart Failure (PHASE4)
- Efficacy Study of Long-term Parenteral Nutrition With SmofKabiven® E in Lung Cancer Patients Under Anticancer Therapy (PHASE4)
- Levosimendan in High Risk Patients Undergoing Cardiac Surgery (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |